FIELD: pharmaceuticals.
SUBSTANCE: invention relates to chemical compounds and their pharmaceutically acceptable salts given in the claims. The invention also relates to a method of treating a tumor, a pharmaceutical composition and the use of compounds or their pharmaceutically acceptable salts according to the invention for treating a tumor.
EFFECT: using a compound as an agonist of interferon genes stimulator (STING) in the treatment of tumors.
6 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING | 2020 |
|
RU2800072C1 |
BENZOTHIOPHENES AND RELATED COMPOUNDS AS STING AGONISTS | 2019 |
|
RU2806274C2 |
AGONISTS OF STING INTERFERON GENE STIMULATOR | 2019 |
|
RU2809022C2 |
SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2017 |
|
RU2750935C2 |
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
TRICYCLIC COMPOUNDS AND THEIR USE | 2016 |
|
RU2724100C2 |
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
TRAF 6 INHIBITORS | 2017 |
|
RU2770404C2 |
COMPOUNDS 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE | 2017 |
|
RU2719599C2 |
Authors
Dates
2024-02-15—Published
2020-08-21—Filed